Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biktarvy
Pharma
Gilead inks Biktarvy settlements with 3 generic drug makers
Thanks to new settlements with a trio of generic drug makers, Gilead Sciences has extended the expected life span of its lucrative HIV treatment.
Fraiser Kansteiner
Oct 7, 2025 7:40am
Potential US budget cuts have limited impact on Gilead: analysts
Mar 26, 2025 2:47pm
ICER calls out drugmakers over 'unsupported' price hikes
Dec 12, 2024 2:24pm
Gilead spotlights lenacapivir in plan to hold on to HIV crown
Dec 11, 2024 10:53am
Gilead aims to shake up HIV PrEP market with long-acting launch
Aug 9, 2024 11:42am
GSK's Dovato matches Gilead's Biktarvy with less weight gain
Jul 23, 2024 4:00am
